MMCAP International’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

MMCAP International’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-140,000	Closed	-$8.95K	–	372
2022 Q4	$8.95K	Hold	140,000	–	–	﹤0.01%	306
2022 Q3	$8K	Hold	140,000	–	–	﹤0.01%	429
2022 Q2	$13K	Hold	140,000	–	–	﹤0.01%	435
2022 Q1	$34K	Hold	140,000	–	–	﹤0.01%	461
2021 Q4	$92K	Sell	140,000 -160,000	-53%	-$111K	0.01%	389
2021 Q3	$198K	Hold	300,000	–	–	0.01%	319
2021 Q2	$258	Hold	300,000	–	–	0.01%	276
2021 Q1	$180K	Buy	+300,000	New	+$212K	0.02%	264

MMCAP International's BIOTW Position: Q1 2023 in Review

MMCAP International sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 140,000 shares — an estimated $8.95K sold.

MMCAP International first reported a position in BIOTW in Q1 2021 and held it in 8 quarters. The position peaked at $198K in Q3 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

MMCAP International reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
MMCAP International sold 140,000 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $8.95K.
MMCAP International first reported a position in Biotech Acquisition Company Warrant in Q1 2021 and held it in 8 quarters.
MMCAP International's Biotech Acquisition Company Warrant position peaked at $198K in Q3 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on MMCAP International's 13F filing for Q1 2023, filed 11 May 2023.